Metformin boosts doxorubicin efficacy and increases CD8 + T cell frequency in mouse breast cancer
- 29 October 2024
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (5) , 2060-2066
Abstract
Purpose Breast cancer is a leading cause of cancer-related deaths among women worldwide. The presence and function of CD8 + T cells in the tumor microenvironment have been associated with better patient outcomes. Drug toxicity has posed a significant challenge to the clinical implementation of chemotherapy-based strategies in cancer treatment. Methods In this study, we employed flow cytometry to investigate the potential synergistic immunomodulatory effects on CD8 + T cells in a mouse model of breast cancer by combining metformin, an anti-diabetic medication, with doxorubicin. Results Through flow cytometry analysis, we observed that the combination of the two drugs led to an increased percentage of CD8 + T cells compared to either drug alone. The modulation of HIF-1α and STAT3 gene expression in the combination group further confirmed the efficacy of this approach. Conclusions Our findings suggest that combining metformin with doxorubicin can enhance the anticancer activity of doxorubicin and decrease its cytotoxicity in a 4T1 breast cancer mouse model.Keywords
This publication has 34 references indexed in Scilit:
- Tumor microenvironment as a complex milieu driving cancer progression: a mini reviewClinical and Translational Oncology, 2024
- Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysisClinical and Translational Oncology, 2024
- STAT3 drives the expression of HIF1alpha in cancer cells through a novel super-enhancerBiochemical and Biophysical Research Communications, 2024
- Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic reviewTranslational Oncology, 2024
- Signaling pathways in cancer metabolism: mechanisms and therapeutic targetsSignal Transduction and Targeted Therapy, 2023
- Metformin and Dapagliflozin Attenuate Doxorubicin-Induced Acute Cardiotoxicity in Wistar Rats: An Electrocardiographic, Biochemical, and Histopathological ApproachCardiovascular Toxicology, 2023
- Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamicsBiochemical Pharmacology, 2021
- Role of CD8+ T lymphocyte cells: Interplay with stromal cells in tumor microenvironmentActa Pharmaceutica Sinica B, 2021
- Glucose Metabolism in Cancer: The Warburg Effect and Beyond2021
- Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacyEuropean Journal of Cancer and Clinical Oncology, 1989